The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9504718 B1

PDF
Full Text
Expired
Date of Patent:
Nov. 29, 2016

Filed:

Mar. 25, 2013
Applicant:

Cytori Therapeutics, Inc., San Diego, CA (US);

Inventors:

John K. Fraser, San Diego, CA (US);

Marc H. Hedrick, Encinitas, CA (US);

Eric Daniels, Encinitas, CA (US);

Assignee:

Cytori Therapeutics, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); A61K 35/35 (2015.01); A61L 27/38 (2006.01); A61L 27/54 (2006.01); A61M 1/36 (2006.01); C12N 5/0775 (2010.01); A61K 35/22 (2015.01); A61K 35/28 (2015.01); A61K 35/44 (2015.01);
U.S. Cl.
CPC ...
A61K 35/35 (2013.01); A61K 35/22 (2013.01); A61K 35/28 (2013.01); A61K 35/44 (2013.01); A61L 27/3834 (2013.01); A61L 27/3886 (2013.01); A61L 27/54 (2013.01); A61M 1/3693 (2013.01); C12N 5/0667 (2013.01); A61L 2300/414 (2013.01); A61L 2300/416 (2013.01); A61L 2430/26 (2013.01); A61M 2202/0437 (2013.01); A61M 2202/08 (2013.01);
Abstract

Cells present in processed lipoaspirate tissue are used to treat patients, including patients with renal conditions, diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, cells present in processed lipoaspirate are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic renal benefit.


Find Patent Forward Citations

Fraser, John. (2016). Methods of using adipose derived regenerative cells in the treatment of renal diseases and disorders (U.S. Patent No. 9504718). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9504718

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…